Lexeo Therapeutics (LXEO) Total Liabilities: 2022-2023
- Lexeo Therapeutics' Total Liabilities fell 67.17% to $32.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $32.5 million, marking a year-over-year decrease of 67.17%. This contributed to the annual value of $25.0 million for FY2022, which is N/A change from last year.
- According to the latest figures from Q3 2023, Lexeo Therapeutics' Total Liabilities is $32.5 million, which was up 30.01% from $25.0 million recorded in Q4 2022.
- Lexeo Therapeutics' Total Liabilities' 5-year high stood at $99.0 million during Q3 2022, with a 5-year trough of $25.0 million in Q4 2022.
- Over the past 2 years, Lexeo Therapeutics' median Total Liabilities value was $32.5 million (recorded in 2023), while the average stood at $52.2 million.
- Data for Lexeo Therapeutics' Total Liabilities shows a maximum YoY slumped of 67.17% (in 2023) over the last 5 years.
- Lexeo Therapeutics' Total Liabilities (Quarterly) stood at $25.0 million in 2022, then slumped by 67.17% to $32.5 million in 2023.
- Its Total Liabilities was $32.5 million in Q3 2023, compared to $25.0 million in Q4 2022 and $99.0 million in Q3 2022.
